| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $442,410 | 13 | 68 |
Sells | $181,544 | 6 | 32 |
| KIRK THOMAS F | director | 7 | $200,338 | 0 | $0 | $200,338 |
| Manko Joseph M. Jr. | director | 2 | $173,908 | 0 | $0 | $173,908 |
| Getz Heather C | director | 2 | $64,932 | 0 | $0 | $64,932 |
| Crowley Thomas Aloysius Jr. | director | 2 | $3,233 | 0 | $0 | $3,233 |
| Morris Milton Mayo | director | 0 | $0 | 1 | $21,150 | $-21,150 |
| Mitchell Micah | Chief Commercial Officer | 0 | $0 | 1 | $77,689 | $-77,689 |
| Kovelman Harry | Chief Medical Officer | 0 | $0 | 4 | $82,705 | $-82,705 |
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological …
Over the last 12 months, insiders at Myomo, Inc. have bought $442,410 and sold $181,544 worth of Myomo, Inc. stock.
On average, over the past 5 years, insiders at Myomo, Inc. have bought $374,942 and sold $252,848 worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIRK THOMAS F (director) — $200,338. Manko Joseph M. Jr. (director) — $173,908. Getz Heather C (director) — $64,932.
The last purchase of 40,002 shares for transaction amount of $50,803 was made by KIRK THOMAS F (director) on 2026‑06‑05.
| 2026-09-11 | Sale | Kovelman Harry | Chief Medical Officer | 15,844 0.0363% | $1.27 | $20,136 | 0.00% | |
| 2026-09-02 | Sale | Morris Milton Mayo | director | 15,000 0.0388% | $1.41 | $21,150 | -5.67% | |
| 2026-08-20 | Sale | Kovelman Harry | Chief Medical Officer | 17,500 0.0408% | $1.73 | $30,329 | -19.83% | |
| 2026-06-05 | KIRK THOMAS F | director | 40,002 0.1027% | $1.27 | $50,803 | +1.56% | ||
| 2026-05-28 | Sale | Kovelman Harry | Chief Medical Officer | 11,536 0.0304% | $1.02 | $11,734 | +18.35% | |
| 2026-05-28 | KIRK THOMAS F | director | 25,000 0.0589% | $0.99 | $24,825 | +18.35% | ||
| 2026-05-27 | Sale | Kovelman Harry | Chief Medical Officer | 20,464 0.0531% | $1.00 | $20,505 | +29.00% | |
| 2026-05-18 | KIRK THOMAS F | director | 43,401 0.1123% | $0.91 | $39,495 | +52.56% | ||
| 2026-05-15 | Manko Joseph M. Jr. | director | 30,367 0.0767% | $0.89 | $26,960 | +40.64% | ||
| 2026-05-15 | KIRK THOMAS F | director | 31,605 0.0818% | $0.91 | $28,748 | +40.64% | ||
| 2026-05-14 | Sale | Mitchell Micah | Chief Commercial Officer | 90,231 0.2264% | $0.86 | $77,689 | +44.14% | |
| 2026-05-14 | Manko Joseph M. Jr. | director | 170,830 0.4283% | $0.86 | $146,948 | +44.14% | ||
| 2026-03-16 | Getz Heather C | director | 20,000 0.0491% | $0.70 | $13,972 | +55.45% | ||
| 2026-03-13 | KIRK THOMAS F | director | 72,000 0.1909% | $0.71 | $51,113 | +62.91% | ||
| 2026-03-12 | Getz Heather C | director | 70,000 0.1927% | $0.73 | $50,960 | +62.77% | ||
| 2025-11-21 | KIRK THOMAS F | director | 2,535 0.0062% | $0.72 | $1,825 | +30.58% | ||
| 2025-11-20 | KIRK THOMAS F | director | 4,902 0.0126% | $0.72 | $3,529 | +38.89% | ||
| 2025-11-19 | Crowley Thomas Aloysius Jr. | director | 385 0.001% | $0.77 | $295 | +38.47% | ||
| 2025-11-18 | Crowley Thomas Aloysius Jr. | director | 4,000 0.0104% | $0.73 | $2,938 | +38.81% | ||
| 2025-08-25 | KIRK THOMAS F | director | 50,000 0.1289% | $1.15 | $57,500 | -14.58% |
| Manko Joseph M. Jr. | director | 2309775 5.8316% | $2.96M | 2 | 0 | |
| KIRK THOMAS F | director | 693865 1.7518% | $888,147.20 | 18 | 0 | <0.0001% |
| Morris Milton Mayo | director | 208391 0.5261% | $266,740.48 | 1 | 1 | +227.36% |
| Getz Heather C | director | 131754 0.3326% | $168,645.12 | 2 | 0 | |
| Mitchell Micah | Chief Commercial Officer | 109478 0.2764% | $140,131.84 | 1 | 5 | +66.14% |
| Kovelman Harry | Chief Medical Officer | 89889 0.2269% | $115,057.92 | 1 | 9 | +335.91% |
| Crowley Thomas Aloysius Jr. | director | 479 0.0012% | $613.12 | 2 | 8 | |
| GUDONIS PAUL R | Chief Executive Officer | 1259013 3.1787% | $1.61M | 11 | 0 | +68.59% |
| HENRY DAVID A | Chief Financial Officer | 352193 0.8892% | $450,807.04 | 5 | 0 | +62.8% |
| SANGHI STEVE | director | 298513 0.7537% | $382,096.64 | 1 | 0 | <0.0001% |
| Naft Jonathan | VP, GENERAL MANAGER | 74114 0.1871% | $94,865.92 | 1 | 0 | <0.0001% |
| Increased Positions | 46 | +70.77% | 3M | +21.87% |
| Decreased Positions | 24 | -36.92% | 2M | -18.19% |
| New Positions | 19 | New | 2M | New |
| Sold Out Positions | 12 | Sold Out | 2M | Sold Out |
| Total Postitions | 87 | +33.85% | 14M | +3.68% |
| Rosalind Advisors, Inc. | $3,753.00 | 9.98% | 3.79M | +195,000 | +5.42% | 2025-09-30 |
| Blackrock, Inc. | $1,648.00 | 4.38% | 1.66M | -11,485 | -0.69% | 2025-09-30 |
| Vanguard Group Inc | $1,470.00 | 3.91% | 1.49M | -2,939 | -0.2% | 2025-09-30 |
| Goldman Sachs Group Inc | $1,023.00 | 2.72% | 1.03M | +666,493 | +181.56% | 2025-09-30 |
| Geode Capital Management, Llc | $796.00 | 2.12% | 804,434 | +135,153 | +20.19% | 2025-09-30 |
| Renaissance Technologies Llc | $705.00 | 1.87% | 712,094 | +170,689 | +31.53% | 2025-09-30 |
| Soleus Capital Management, L.P. | $697.00 | 1.85% | 704,275 | 0 | 0% | 2025-09-30 |
| Clearstead Advisors, Llc | $421.00 | 1.12% | 425,600 | +11 | +<0.01% | 2025-09-30 |
| State Street Corp | $376.00 | 1% | 380,290 | +38,465 | +11.25% | 2025-09-30 |
| Aqr Capital Management Llc | $291.00 | 0.77% | 293,949 | +293,949 | New | 2025-09-30 |